Nektar Therapeutics
NKTR
#4556
Rank
NZ$3.78 B
Marketcap
NZ$131.83
Share price
5.66%
Change (1 day)
638.52%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$7.17

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$7.34. In 2024 the company made an earnings per share (EPS) of NZ-$6.07 an increase over its 2023 EPS that were of NZ-$37.98.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.1718.08%
2024NZ-$6.07-84.02%
2023NZ-$37.98-25.89%
2022NZ-$51.24-31.12%
2021NZ-$74.3914.86%
2020NZ-$64.77-1.19%
2019NZ-$65.55-163.96%
2018NZ$102.49-725.4%
2017NZ-$16.39-42.73%
2016NZ-$28.6183.33%
2015NZ-$15.6139.53%
2014NZ-$11.18-69.29%
2013NZ-$36.42-6.67%
2012NZ-$39.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.32-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.36-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.85-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.21-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.68-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.28-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.59-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland